Open source drug discovery with bioclipse

Current Topics in Medicinal Chemistry

Volumn 12, Issue 18, 2012, Pages 1980-1986

  Spjuth, Ola ^a   Carlsson, Lars ^b   Alvarsson, Jonathan ^a   Georgiev, Valentin ^a   Willighagen, Egon ^c   Eklund, Martin ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b ASTRAZENECA R AND D   (Sweden)

^c MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Adme; Bioclipse; Chemical liability assessment; Cheminformatics; Computational toxicology; Decision support; Drug discovery; Open source; Virtual screening

Indexed keywords

ABSORPTION; ARTICLE; BIOINFORMATICS; CHEMICAL STRUCTURE; COMPUTER MODEL; COMPUTER PROGRAM; DATA ANALYSIS SOFTWARE; DECISION SUPPORT SYSTEM; EXCRETION; KNOWLEDGE; METABOLISM; QUANTITATIVE STRUCTURE ACTIVITY RELATION;

ABSORPTION; ALGORITHMS; DECISION SUPPORT TECHNIQUES; DRUG DISCOVERY; DRUG EVALUATION, PRECLINICAL; PHARMACOKINETICS; SOFTWARE; TOXICOLOGY;

EID: 84874898081     PISSN: 15680266     EISSN: 18734294     Source Type: Journal    
DOI: 10.2174/156802612804910287     Document Type: Article

References (67)

1. W. L. The case for open-source software in drug discovery. Drug Discov. Today, 2005, 10, 213-217.
2. Edwards, A. Open-source science to enable drug discovery. Drug Discov. Today, 2008, 13, 731-733.
3. Geldenhuys, W. J.; Gaasch, K. E.; Watson, M.; Allen, D. D.; Van der Schyf, C. J. Optimizing the use of open-source software applications in drug discovery. Drug Discov. Today, 2006, 11, 127-132.
4. Oinn, T.; Addis, M.; Ferris, J.; Marvin, D.; Senger, M.; Greenwood, M.; Carver, T.; Glover, K.; Pocock, M. R.; Wipat, A.; Li, P. Taverna: a tool for the composition and enactment of bioinformatics workflows. Bioinformatics, 2004, 20, 3045-3054.
5. W. A. Scientific workflow systems: Pipeline Pilot and KNIME. J Comput Aided Mol. Des., 2012,
6. Giardine, B.; Riemer, C.; Hardison, R. C.; Burhans, R.; Elnitski, L.; Shah, P.; Zhang, Y.; Blankenberg, D.; Albert, I.; Taylor, J.; Miller, W.; Kent, W. J.; Nekrutenko, A. Galaxy: a platform for interactive large-scale genome analysis. Genome Res., 2005, 15, 1451-1455.
7. Shannon, P. T.; Reiss, D. J.; Bonneau, R.; Baliga, N. S. The Gaggle: an open-source software system for integrating bioinformatics software and data sources. BMC Bioinformatics, 2006, 7, 176.
8. Siepel, A.; Farmer, A.; Tolopko, A.; Zhuang, M.; Mendes, P.; Beavis, W.; Sobral, B. ISYS: a decentralized, component-based approach to the integration of heterogeneous bioinformatics resources. Bioinformatics, 2001, 17, 83-94.
9. Spjuth, O.; Helmus, T.; Willighagen, E. L.; Kuhn, S.; Eklund, M.; Wagener, J.; Murray-Rust, P.; Steinbeck, C.; Wikberg, J. E. S. Bioclipse: an open source workbench for chemo-and bioinformatics. BMC Bioinformatics 2007, 8, 59.
10. Spjuth, O.; Alvarsson, J.; Berg, A.; Eklund, M.; Kuhn, S.; Masak, C.; Torrance, G.; Wagener, J.; Willighagen, E. L.; Steinbeck, C.; Wikberg, J. E. S. Bioclipse 2: a scriptable integration platform for the life sciences. BMC Bioinformatics, 2009, 10, 397.
11. Goble, C. A.; Bhagat, J.; Aleksejevs, S.; Cruickshank, D.; Michaelides, D.; Newman, D.; Borkum, M.; Bechhofer, S.; Roos, M.; Li, P.; De Roure, D. Myexperiment: a repository and social network for the sharing of bioinformatics workflows. Nucleic Acids Res., 2010, 38 Suppl, W677-W682.
12. Wagener, J.; Spjuth, O.; Willighagen, E. L.; Wikberg, J. E. S. XMPP for cloud computing in bioinformatics supporting discovery and invocation of asynchronous web services. BMC Bioinformatics, 2009, 10, 279.
13. Guha, R.; Howard, M. T.; Hutchison, G. R.; Murray-Rust, P.; Rzepa, H.; Steinbeck, C.; Wegner, J.; Willighagen, E. L. The Blue Obelisk-interoperability in chemical informatics. J. Chem. Inf. Model, 2006, 46, 991-998.
14. O'Boyle, N. M. et al. Open Data, Open Source and Open Standards in chemistry: The Blue Obelisk five years on. J. Cheminform., 2011, 3, 37.
15. OSGi Alliance. http://www.osgi.org.
16. Shannon, P.; Markiel, A.; Ozier, O.; Baliga, N. S.; Wang, J. T.; Ramage, D.; Amin, N.; Schwikowski, B.; Ideker, T. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res., 2003, 13, 2498-2504.
17. Spjuth, O.; Willighagen, E. L.; Guha, R.; Eklund, M.; Wikberg, J. E. Towards interoperable and reproducible QSAR analyses: Exchange of datasets. J. Cheminform., 2010, 2, 5.
18. Spjuth, O.; Eklund, M.; Ahlberg Helgee, E.; Boyer, S.; Carlsson, L. Integrated decision support for assessing chemical liabilities. J Chem Inf Model, 2011, 51, 1840-1847.
19. Carlsson, L.; Spjuth, O.; Adams, S.; Glen, R. C.; Boyer, S. Use of historic metabolic biotransformation data as a means of anticipating metabolic sites using MetaPrint2D and Bioclipse. BMC Bioinformatics, 2010, 11, 362.
20. Alvarsson, J.; Andersson, C.; Spjuth, O.; Larsson, R.; Wikberg, J. E. S. Brunn: an open source laboratory information system for microplates with a graphical plate layout design process. BMC Bioinformatics, 2011, 12, 179.
21. Willighagen, E. L.; Jeliazkova, N.; Hardy, B.; Grafstrom, R. C.; Spjuth, O. Computational toxicology using the OpenTox application programming interface and Bioclipse. BMC Res. Notes, 2011, 4, 487.
22. Willighagen, E.; Alvarsson, J.; Andersson, A.; Eklund, M.; Lampa, S.; Lapins, M.; Spjuth, O.; Wikberg, J. Linking the Resource Description Framework to cheminformatics and proteochemometrics. Journal of Biomedical Semantics, 2011, 2, S6+.
23. Spjuth, O.; Eklund, M.; Lapins, M.; Junaid, M.; Wikberg, J. E. S. Services for prediction of drug susceptibility for HIV proteases and reverse transcriptases at the HIV drug research centre. Bioinformatics. 2011, 27, 1719-1720.
24. Steinbeck, C.; Hoppe, C.; Kuhn, S.; Floris, M.; Guha, R.; Willighagen, E. L. Recent developments of the Chemistry Development Kit (CDK) -an open-source Java library for chemo-and bioinformatics. Curr. Pharm. Des. 2006, 12, 2111-2120.
25. Krause, S.; Willighagen, E.; Steinbeck, C. JChemPaint -Using the Collaborative Forces of the Internet to Develop a Free Editor for 2D Chemical Structures. Molecules, 2000, 5, 93-98.
26. Jmol: an open-source Java viewer for chemical structures in 3D. http://www.jmol.org/.
27. Murray-Rust, P.; Rzepa, H. S. Chemical markup, XML and the World-Wide Web. 2. Information objects and the CMLDOM. J. Chem. Inf. Comput. Sci., 2001, 41, 1113-1123.
28. Vainio, M. J.; Johnson, M. S. Generating conformer ensembles using a multiobjective genetic algorithm. J Chem Inf Model 2007, 47, 2462-2474.
29. Lowe, D. M.; Corbett, P. T.; Murray-Rust, P.; Glen, R. C. Chemical name to structure: OPSIN, an open source solution. Journal of chemical information and modeling 2011, 51, 739-753.
30. Dearden, J. C. In silico prediction of drug toxicity. J. Comput.Aided Mol. Des., 2003, 17, 119-127.
31. Martin, Y. C.; Kofron, J. L.; Traphagen, L. M. Do structurally similar molecules have similar biological activity? J. Med. Chem., 2002, 45, 4350-4358.
32. Benigni, R. Chemical structure of mutagens and carcinogens and the relationship with biological activity. J. Exp. Clin. Cancer Res., 2004, 23, 5-8.
33. Akamatsu, M. Importance of physicochemical properties for the design of new pesticides. J. Agric. Food Chem., 2011, 59, 2909-2917.
34. Flower, D. R. On the Properties of Bit String-Based Measures of Chemical Similarity. Journal of Chemical Information and Computer Sciences, 1998, 38, 379-386.
35. Xue, L.; Stahura, F. L.; Bajorath, J. Similarity search profiling reveals effects of fingerprint scaling in virtual screening. J. Chem. Inf. Comput Sci., 2004, 44, 2032-2039.
36. Varnek, A. Fragment descriptors in structure-property modeling and virtual screening. Methods Mol. Biol., 2011, 672, 213-243.
37. Guha, R. On the interpretation and interpretability of quantitative structure-activity relationship models. J. Comput Aided Mol. Des., 2008, 22, 857-871.
38. Carlsson, L.; Helgee, E. A.; Boyer, S. Interpretation of nonlinear QSAR models applied to Ames mutagenicity data. J. Chem. Inf. Model, 2009, 49, 2551-2558.
39. Hasegawa, K.; Funatsu, K. Non-linear modeling and chemical interpretation with aid of support vector machine and regression. Curr. Comput. Aided Drug Des., 2010, 6, 24-36.
40. Gamo, F.-J.; Sanz, L. M.; Vidal, J.; de Cozar, C.; Alvarez, E.; Lavandera, J.L.; Vanderwall, D. E.; Green, D. V. S.; Kumar, V.; Hasan, S.; Brown, J. R.; Peishoff, C. E.; Cardon, L. R.; GarciaBustos, J. F. Thousands of chemical starting points for antimalarial lead identification. Nature, 2010, 465, 305-310.
41. Gellibert, F.; Fouchet, M.-H.; Nguyen, V.-L.; Wang, R.; Krysa, G.; de Gouville, A.-C.; Huet, S.; Dodic, N. Design of novel quinazoline derivatives and related analogues as potent and selective ALK5 inhibitors. Bioorg. Med. Chem. Lett., 2009, 19, 2277-2281.
42. Willighagen, E.R.A.; Grafström, R. C.; Hardy, B.; Jeliazkova, N.; Spjuth, O. Open Source Software in Life Science Research: Practical Solutions to Common Challenges in the Pharmaceutical Industry and Beyond; Biohealthcare Publishing Ltd, 2012.
43. Kazius, J.; McGuire, R.; Bursi, R. Derivation and validation of toxicophores for mutagenicity prediction. J. Med. Chem., 2005, 48, 312-320.
44. Fitzpatrick, R. B. CPDB: Carcinogenic Potency Database. Med. Ref. Serv. Q., 2008, 27, 303-311.
45. Denison, M. S.; Nagy, S. R. Activation of the aryl hydrocarbon receptor by structurally diverse exogenous and endogenous chemicals. Annu. Rev. Pharmacol. Toxicol., 2003, 43, 309-334.
46. Ashby, J. Fundamental structural alerts to potential carcinogenicity or non-carcinogenicity. Env. Mutagen., 1985, 7, 919-921.
47. Hardy, B. et al. Collaborative development of predictive toxicology applications. Journal of Cheminformatics, 2010, 2, 7+.
48. Rydberg, P.; Vasanthanathan, P.; Oostenbrink, C.; Olsen, L. Fast prediction of cytochrome P450 mediated drug metabolism. Chem. Med. Chem., 2009, 4, 2070-2079.
49. Patlewicz, G.; Jeliazkova, N.; Safford, R. J.; Worth, A. P.; Aleksiev, B. An evaluation of the implementation of the Cramer classification scheme in the Toxtree software. SAR QSAR Environ. Res., 2008, 19, 495-524.
50. Caldwell, G. W.; Yan, Z.; Tang, W.; Dasgupta, M.; Hasting, B. ADME optimization and toxicity assessment in early-and latephase drug discovery. Curr. Top. Med. Chem., 2009, 9, 965-980.
51. Lipinski, C. A.; Lombardo, F.; Dominy, B. W.; Feeney, P. J. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Deliv. Rev., 2001, 46, 3-26.
52. Wang, J.; Krudy, G.; Hou, T.; Zhang, W.; Holland, G.; Xu, X. Development of reliable aqueous solubility models and their application in druglike analysis. J. Chem. Inf. Model, 2007, 47, 1395-404.
53. Li, H.; Yap, C. W.; Ung, C. Y.; Xue, Y.; Cao, Z. W.; Chen, Y. Z. Effect of selection of molecular descriptors on the prediction of blood-brain barrier penetrating and nonpenetrating agents by statistical learning methods. J. Chem. Inf. Model., 2005, 45, 1376-1384.
54. Chen, L.; Li, Y.; Zhao, Q.; Peng, H.; Hou, T. ADME evaluation in drug discovery. 10. Predictions of P-glycoprotein inhibitors using recursive partitioning and naive Bayesian classification techniques. Mol. Pharm., 2011, 8, 889-900.
55. Wienkers, L. C.; Heath, T. G. Predicting in vivo drug interactions from in vitro drug discovery data. Nat.Rev. Drug Discov., 2005, 4, 825-833.
56. Glen, R. C., Robert C; Bender, A.; Arnby, C. H.; Carlsson, L.; Boyer, S.; Smith, J. Circular fingerprints: flexible molecular descriptors with applications from physical chemistry to ADME. IDrugs, 2006, 9, 199-204.
57. Gonzalez, F. J.; H, T. R. Goodman & Gilman's The Pharmacological Basis of Therapeutics; McGraw-Hill, 2005.
58. Hertzberg, R. P.; Pope, A. J. High-throughput screening: new technology for the 21st century. Current Opinion in Chemical Biology, 2000, 4, 445-451.
59. Walters, W.; Stahl, M. T.; Murcko, M. A. Virtual screening-an overview. Drug Discovery Today 1998, 3, 160-178.
60. Spjuth, O.; Georgiev, V.; Carlsson, L.; Willighagen, E.; Alvarsson, J.; Berg, A.; Wikberg, J. E. S.; Eklund, M. Bioclipse-R: Integrating management and visualization of life science data with statistical analysis. Bioinformatics 2012, Nov. 23 [Epub ahead of print].
61. Knox, C.; Law, V.; Jewison, T.; Liu, P.; Ly, S.; Frolkis, A.; Pon, A.; Banco, K.; Mak, C.; Neveu, V.; Djoumbou, Y.; Eisner, R.; Guo, A. C.; Wishart, D. S. DrugBank 3.0: a comprehensive resource for'omics' research on drugs. Nucleic Acids Res., 2011, 39, D1035-D1041.
62. Williams, A. J.; Harland, L.; Groth, P.; Pettifer, S.; Chichester, C.; Willighagen, E. L.; Evelo, C. T.; Blomberg, N.; Ecker, G.; Goble, C.; Mons, B. Open PHACTS: semantic interoperability for drug discovery. Drug Discov. Today, 2012,
63. Gaulton, A.; Bellis, L. J.; Bento, A. P.; Chambers, J.; Davies, M.; Hersey, A.; Light, Y.; McGlinchey, S.; Michalovich, D.; AlLazikani, B.; Overing-ton, J. P. ChEMBL: a large-scale bioactivity database for drug discovery. Nucleic Acids Res., 2012, 40, D1100-D1107.
64. Degtyarenko, K.; de Matos, P.; Ennis, M.; Hastings, J.; Zbinden, M.; Mc-Naught, A.; Alcantara, R.; Darsow, M.; Guedj, M.; Ashburner, M. ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Research, 2008, 36, D344-D350.
65. Kuhn, M.; Campillos, M.; Letunic, I.; Jensen, L. J.; Bork, P. A side effect resource to capture phenotypic effects of drugs. Molecular Systems Biology, 2010, 6.
66. Samwald, M.; Jentzsch, A.; Bouton, C.; Kallese, C. S.; Willighagen, E.; Hajagos, J.; Marshall, M. S.; Prud'hommeaux, E.; Hassenzadeh, O.; Pichler, E.; Stephens, S. Linked open drug data for pharmaceutical research and development. J. Cheminform., 2011, 3, 19.
67. Hastings, J.; Chepelev, L.; Willighagen, E.; Adams, N.; Steinbeck, C.; Dumontier, M. The chemical information ontology: provenance and disambiguation for chemical data on the biological semantic web. PLoS One, 2011, 6, e25513.